AZITRA INC (AZTR) Stock Price, Quote, News and Overview
NYSEARCA:AZTR - American Stock Exchange - US05479L2034 - Common Stock - Currency: USD
AZTR Quote, Performance and Key Statistics
AZITRA INC
NYSEARCA:AZTR (1/24/2025, 8:26:22 PM)
After market: 0.2551 -0.01 (-4.78%)0.2679
+0.02 (+6.27%)
The current stock price of AZTR is 0.2679 USD. In the past month the price decreased by -36.18%. In the past year, price decreased by -99.35%.
AZTR Latest News, Press Releases and Analysis
Friday's after hours session: top gainers and losers
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
These stocks have an unusual volume in today's session
In today's session, these stocks are experiencing unusual volume.
Unusual volume stocks in Wednesday's session
Unusual volume stocks are being observed in Wednesday's session.
Top movers in Wednesday's session
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
AZTR Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.84 | 300.94B | ||
| AMGN | AMGEN INC | 14.33 | 148.05B | ||
| GILD | GILEAD SCIENCES INC | 21.01 | 115.99B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 862 | 113.22B | ||
| REGN | REGENERON PHARMACEUTICALS | 14.88 | 74.26B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.80B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 35.95B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.47B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.64B | ||
| NTRA | NATERA INC | N/A | 22.13B | ||
| BIIB | BIOGEN INC | 8.95 | 21.30B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 17.52B |
Related stock screener links
About AZTR
Company Profile
Azitra Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Branford, Connecticut and currently employs 10 full-time employees. The company went IPO on 2023-06-16. Azitra, Inc. is an early-stage clinical biopharmaceutical company. The firm is focused on developing advanced therapies for precision dermatology using engineered proteins and topical live biotherapeutic products. The company has built a proprietary platform that includes a microbial library comprised of approximately 1,500 unique bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen its library of strains for drug-like molecules. The Company’s product ATR-12 is a genetically modified strain of S. epidermidis for treating the orphan disease, Netherton syndrome, a chronic and fatal disease of the skin. Its product ATR-04 is a genetically modified strain of S. epidermidis for treating the papulopustular rash. Its product ATR-01 is a human filaggrin protein for treating ichthyosis vulgaris, a chronic, xerotic (abnormally dry), and scaly skin disease.
Company Info
AZITRA INC
21 Business Park Drive, Suite 6
Branford CONNECTICUT US
Employees: 10
Company Website: https://azitrainc.com/
Phone: 12034890183
AZTR FAQ
What is the stock price of AZTR?
The current stock price of AZTR is 0.2679 USD.
What is the symbol for AZITRA INC stock?
The exchange symbol of AZITRA INC is AZTR and it is listed on the American Stock Exchange exchange.
On which exchange is AZTR stock listed?
AZTR stock is listed on the American Stock Exchange exchange.
Is AZTR a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for AZTR, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of AZTR.
Does AZTR stock pay dividends?
AZTR does not pay a dividend.
What is the Price/Earnings (PE) ratio of AZTR?
AZTR does not have a PE ratio as the earnings reported over the last twelve months were negative (-7.48).
What is the Short Interest ratio of AZTR stock?
The outstanding short interest for AZTR is 7.31% of its float.
AZTR Technical Analysis
AZTR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AZTR. While AZTR seems to be doing ok healthwise, there are quite some concerns on its profitability.
AZTR Financial Highlights
Over the last trailing twelve months AZTR reported a non-GAAP Earnings per Share(EPS) of -7.48. The EPS decreased by -127.06% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -92.34% | ||
| ROE | -112.04% | ||
| Debt/Equity | 0 |
AZTR Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to AZTR. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 97.92% and a revenue growth -68.88% for AZTR